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The transactive response (TAR) DNA-binding protein 
of 43kDa (TDP-43) is an RNA binding protein en-
coded by the TARDPB gene. Abnormal aggregations 
of TDP-43 in neurons in the form of neuronal cyto-
plasmic inclusions (NCI) are the pathological hallmark 
of frontotemporal lobar degeneration with TDP-43 
proteinopathy (FTLD-TDP). To investigate the role of 
TDP-43 in FTLD-TDP, the spatial patterns of the NCI 
were studied in frontal and temporal cortex of FTLD-
TDP cases using a phosphorylation dependent anti-
TDP-43 antibody (pTDP-43). In many regions, the 
NCI formed clusters and the clusters were distributed 
regularly parallel to the tissue boundary. In about 35% 
of cortical regions, cluster size of the NCI was within 
the size range of the modular columns of the cortex. 
The spatial patterns of the pTDP-immunoreactive in-
clusions were similar to those revealed by a phos-
phorylation-independent anti-TDP-43 antibody and 
also similar to inclusions characterized by other mo-
lecular pathologies such as tau, a-synuclein and ‘fused 
in sarcoma’ (FUS). In conclusion, the data suggest de-
generation of cortical and hippocampal anatomical 
pathways associated with accumulation of cellular 
pTDP-43 is characteristic of FTLD-TDP. In addition, 
the data are consistent with the hypothesis of cell to 
cell transfer of pTDP-43 within the brain. 
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Spatial patterns of phosphorylation-dependent TDP-43-immunoreactive 
neuronal cytoplasmic inclusions (NCI) in frontotemporal lobar degeneration 
with TDP-43 proteinopathy (FTLD-TDP) 
Introduction 
 
The transactive response (TAR) DNA-binding protein 
of 43kDa (TDP-43) is an RNA binding protein en-
coded by the highly conserved TARDPB gene. TDP 
proteins have a glycine-rich domain and are believed 
to carry out essential cellular functions including the 
regulation of transcription, alternate splicing, and act-
ing as a framework for nuclear bodies (Wang et al. 
2004).  
 Recent studies suggest a significant role for 
TDP-43 in neurodegenerative disease. Hence, TDP-43 
is a major pathological protein in frontotemporal lobar 
degeneration with TDP-43 proteinopathy (FTLD-TDP) 
(Cairns et al. 2007a), a disorder that accounts for ap-
proximately 10% of early-onset dementias. FTLD-
TDP is characterized by a widespread atrophy of the 
brain largely affecting the frontal, temporal, and parie-
tal lobes. In addition, there is the presence of abnormal 
aggregates of TDP-43 protein within the cytoplasm of 
neurons (Cairns et al. 2007b) termed neuronal cyto-
plasmic inclusions (NCI).  
 Various genetic defects have been identified in 
FTLD-TDP cases, the majority being caused by muta-
tion of the progranulin (GRN) gene (FTLD-TDP-
GRN) (Baker et al. 2006, Behrens et al. 2007, Cruts et 
al. 2006, Mukerjee et al. 2006, Rademakers & Hutton 
2007). A less prevalent disorder, FTLD with valosin-
containing protein (VCP) gene mutation (Forman et al. 
2006) has TDP-43-immunoreactive inclusions, and 
familial cases have also been shown to be caused by 
ubiquitin-associated binding protein 1 (UBAP1) 
(Rollinson et al. 2009) and the chromosome-9 open 
reading frame 72 (C90RF72) gene (Luty et al. 2008, 
Renton et al. 2011).  
 NCI characterized by various molecular pa-
thologies are a common feature of neurodegenerative 
disease (Goedert et al. 2001). Most disorders are asso-
ciated with abnormal cellular aggregations of tau 
(tauopathies), a-synuclein (synucleinopathies), TDP-
43, or ‘fused in sarcoma’ (FUS) proteins (Armstrong et 
al. 2011). In the cerebral cortex of many disorders, the 
various molecular types of NCI have a distinct spatial 
pattern, i.e., they occur in clusters which exhibit a 
regular periodicity parallel to the pia mater (Armstrong 
et al. 1997, 1998, 1999, 2004, 2011). This spatial pat-
tern suggests that the NCI develop in relation to clus-
ters of cells associated with the columnar structure of 
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the cortex and specifically, the anatomical projec-
tions which connect different cortical gyri (cortico-
cortical projections) and the cortex with the hippo-
campus (cortico-hippocampal projections). In previ-
ous studies, the spatial patterns of the NCI have 
been studied using a phosphorylation independent 
anti-TDP-43 antibody (Armstrong et al. 2010). 
However in FTLD-TDP, TDP-43 is redistributed 
from the nucleus to the cytoplasm, is ubiquinated, 
hyperphosphorylated, and then cleaved to generate 
C-terminal fragments (Neumann et al. 2007). 
Hence, the objective of the present study was to 
determine in a larger series of FTLD-TDP cases 
whether the phosphorylated TDP-43-
immunoreactive NCI (pTDP-43) exhibit a similar 
spatial pattern to that revealed by anti-TDP-43. 
 
Materials and Methods 
 
Cases  
Thirty-two clinically and neuropathologically veri-
fied cases of FTLD-TDP (16 male, 16 female) (see 
Table 1) were obtained from the Knight Alz-
heimer’s Disease Research Center, Department of 
Neurology, Washington University School of Medi-
cine, St. Louis, MO, USA. All cases exhibited 
FTLD with neuronal loss, varying degrees of mi-
crovacuolation of the superficial cortical laminae, 
and a reactive astrocytosis consistent with proposed 
diagnostic criteria for FTLD-TDP (Cairns et al. 
2007b). Of the 32 cases, 20 were identified as fa-
milial (at least one or more first degree relatives 
affected) and of these, 10 cases were identified as 
having GRN mutations (Baker et al. 2006, Behrens 
et al. 2007, Cruts et al. 2006, Muckerjee et al. 
2006, ), one had a VCP gene mutation and one case 
was associated with ubiquitin-associated binding 
protein 1 (UBAP1) (Rollinson et al. 2009). The ma-
jority (N = 7) of the GRN cases come from a single 
hereditary dysphasic disinhibition dementia 
(HDDD) family (HDDD2) (Mukherjee et al. 2006) 
and the remainder (N = 3) from the HDDD1 family 
(Behrens et al. 2007). No genetic defects have been 
identified to date in the remaining familial cases (N 
= 8) and none of these had a strong autosomal 
dominant pattern of inheritance. 
  
Histological methods 
 After death, the consent of the next-of-kin 
was obtained for brain removal, following local 
Ethical Committee procedures and the 1995 Decla-
ration of Helsinki (as modified in Edinburgh, 2000). 
Tissue blocks were taken from the frontal lobe at 
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Table 1. Summary of demographic features, gross brain weight, 
and familial status of the 32 cases of frontotemporal lobar degen-
eration with TDP-43 proteinopathy (FTLD-TDP). Abbreviations: 
M/F = male/female, Fm/S = Familial/Sporadic, - indicates data 
not available, GRN = cases caused by progranulin gene muta-
tions, VCP = case caused by valosin-containing protein, UBAP1 
= case caused by ubiquitin-associated binding protein 1  
Case M/F 
Onset 
(years) 
Duration 
(years) 
Age 
(years) 
BW 
(gm) 
Fm/S 
1. M 57 8 65 960 S 
2. F 72 12 84 900 S 
3. F 61 16 77 950 S 
4. F 68 6 74 975 GRN 
5. M 52 13 65 1300 GRN 
6. M 66 16 82 - S 
7. F 69 15 84 970 GRN 
8. M 60 6 66 - GRN 
9. F 65 12 77 810 GRN 
10. M 52 15 67 960 GRN 
11. M 74 6 80 1270 Fm 
12. F - - 67 990 S 
13. F 59 9 68 650 Fm 
14. M 74 1 75 1360 S 
15. M 60 11 71 1450 Fm 
16. M 43 7 50 1060 Fm 
17. M 55 11 66 1005 GRN 
18. F 63 3 66 950 S 
19. F 58 9 67 880 GRN 
20. F 64 19 83 720 Fm 
21. F 69 4 71 1070 S 
22. M 38 9 47 1185 VCP 
23. F - - 73 720 S 
24. M 50 18 68 1170 S 
25. M 58 8 66 1080 Fm 
26. F 65 13 78 960 Fm 
27. M 57 6 63 1080 GRN 
28. M 51 11 62 880 UBAP1 
29. F 71 13 84 960 S 
30. F 73 9 82 - GRN 
31. F 58 8 66 - Fm 
32. M 71 8 79 1150 GRN 
the level of the genu of the corpus callosum to study 
the middle frontal gyrus (MFG) (B32) and the tempo-
ral lobe at the level of the lateral geniculate nucleus to 
study the superior temporal gyrus (STG) (B20), para-
hippocampal gyrus (PHG) (B28), CA1/2 sectors of the 
hippocampus, and dentate gyrus (DG). Tissue was 
fixed in 10% phosphate buffered formal-saline and 
embedded in paraffin wax. Immunohistochemistry 
(IHC) was performed on 4 to 10µm sections with a 
mouse monoclonal antibody that specifically recog-
nizes phosphorylated pTDP-43 (dilution 1:40,000; 
pS409/410-1, Clone 11-9, Cosmo Bio USA, Inc., 
Carlsbad, CA, USA). Sections were counterstained 
with haematoxylin.  
 
Morphometric methods 
NCI (Figure 1) were counted along strips of tissue 
(1,600 to 3,200 µm in length) located parallel to the 
pia mater in 250 x 50 µm sample fields arranged con-
tiguously as reported previously (Armstrong 2003). 
The sample fields were located both in the upper 
(laminae II/III) and lower (laminae V/VI) cortex, the 
short edge of the sample field being orientated parallel 
with the pia mater and aligned with guidelines marked 
on the slide. In the hippocampus, the features were 
counted in the cornu ammonis (CA) sectors CA1 and 
CA2, the short dimension of the contiguous sample 
field being aligned with the alveus. In addition, NCI 
have been observed in the dentate gyrus (DG) in FTLD
-TDP (Kovari et al. 2004, Mackenzie et al. 2006, 
Woulfe et al. 2001) and the sample field was aligned 
with the upper edge of the granule cell layer. The NCI 
were identified as round, spicular, or skein-like inclu-
sions (Davidson et al. 2007, Yaguchi et al. 2004).  
 
Data analysis 
To determine the spatial patterns of the NCI, the data 
were analysed by spatial pattern analysis described 
previously (Armstrong 1993a, 1997; 2006). This 
method uses the variance-mean ratio (V/M) to deter-
mine whether the NCI were distributed randomly (V/
M = 1), regularly (V/M < 1), or were clustered (V/M > 
1) along a strip of tissue. V/M was plotted against vari-
ous field sizes, e.g., 50 x 250 µm, 100 x 250 µm, 200 x 
250 µm etc., to determine whether the clusters of NCI 
were regularly or randomly distributed and to estimate 
the mean cluster size. A V/M peak indicates the pres-
ence of regularly spaced clusters while an increase in 
V/M to an asymptotic level suggests the presence of 
randomly distributed clusters. The statistical signifi-
cance of a peak was tested using the ‘t’ distribution 
(Armstrong 1997).  
 Cluster sizes of the NCI in different brain re-
gions were compared using analysis of variance 
(ANOVA). First, upper laminae data of the cortical 
regions (MFG, ITG, PHG) were compared with CA1/2 
sectors of the hippocampus and DG using one-way 
ANOVA. If significant differences were observed be-
tween regions then ‘Fisher’s protected least significant 
difference’ was used as a post-hoc test. Second, a simi-
lar analysis was carried out but substituting the lower 
cortical laminae data. Third, the data as a whole were 
analysed using a two-factor ANOVA to determine 
whether brain region, cortical lamina, or interaction 
between the two factors affected cluster size. 
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Figure 1. Neuronal cytoplasmic inclusions (NCI) (arrows) 
comprising aggregations of phosphorylated TDP-43 (pTDP-
43) in the dentate gyrus (DG) granule cell layer in fronto-
temporal lobar degeneration with TDP-43 proteinopathy 
(FTLD-TDP) (anti-pTDP-43 immunohistochemistry, 
haematoxylin, bar = 30μm). 
Figure 2. Examples of the spatial patterns exhibited by 
pTDP-43-immunoreactive neuronal cytoplasmic inclusions 
(NCI) in frontotemporal lobar degeneration with TDP-43 
proteinopathy (FTLD-TDP) (MFG = Middle frontal gyrus, 
STG = Superior temporal gyrus, ** significant Variance/
Mean peaks). 
Results 
 
An example of the typical appearance of pTDP-43-
immunoreactive NCI in the granule cell layer of the 
DG is shown in Figure 1. Statistical analysis is often 
necessary to reveal the spatial patterns of protein inclu-
sions in the tissue. However, two NCI are present in 
the centre of the section and a single NCI some dis-
tance to its left. 
 The spatial patterns shown by the pTDP-43 
immunoreactive NCI are shown in Figure 2. In the up-
per laminae of the MFG, there was a V/M peak at a 
field size of 400 μm, suggesting clusters of NCI of 
mean dimension 400 μm regularly distributed parallel 
to the pia mater. Similarly, in the upper laminae of the 
STG, there was a V/M peak at 50 μm suggesting 
smaller clusters of regularly distributed NCI. 
 A summary of the spatial patterns exhibited by 
the NCI in all cases and regions is shown in Table 2. 
The commonest spatial pattern exhibited by the NCI 
was clustering with the clusters regularly distributed 
parallel to the tissue boundary and evident in 84/175 
(48%) of brain regions analysed. In about 35% of cor-
tical regions, cluster size of the NCI was within the 
range of size of the modular columns which form the 
cells of origin of the cortico-cortical projections. NCI 
were also randomly distributed in a total of 44/176 
(25%). Clustering on a larger scale (clusters > 800 μm) 
and a more uniform distribution of NCI relative to the 
tissue boundary were relatively uncommon. NCI ex-
hibited a similar range of spatial patterns between 
brain regions and in different cases of FTLD-TDP. 
 A comparison of cluster sizes of the NCI be-
tween brain regions is shown in Figure 3. Mean cluster 
sizes in all regions were <350 mm, the SE indicating 
significant variation between cases. A one-way 
ANOVA of the data comparing upper laminae of the 
cortical regions studied with sectors CA1/2 and the 
DG suggested no significant differences in mean clus-
ter sizes of NCI (F = 1.33, P > 0.05). Similarly, when 
lower laminae data were analysed, there were no sig-
nificant differences between regions (F = 0.23, P > 
0.05). However, the two-factor ANOVA suggested 
significant differences in cluster size between laminae 
(F = 6.30, P < 0.05), with larger clusters of NCI in the 
upper cortical lamiane, a pattern consistent in all corti-
cal areas studied (Lamina x Region interaction, F = 
0.27, P > 0.05).  
 
Discussion 
 
The data suggest that in the majority of regions the 
NCI occurred in clusters that exhibit a regular pattern 
parallel to the tissue boundary. This spatial pattern is 
similar to that previously reported using a phosphory-
lation-independent antibody (Armstrong 2011). The 
advantage of pTDP-43 antibodies is that they do not 
label normal physiological TDP-43 (Armstrong et al. 
2011, Hasegawa et al. 2008, Neumann et al. 2009, 
Olive et al. 2009, Schwab et al. 2009, ) thus enabling 
the TDP-43-immunoreactive inclusions to be more 
clearly visualized and quantified.  In addition, the spa-
tial pattern of the NCI is similar to that reported for 
different molecular types of cellular inclusion charac-
terized by tau (Armstrong et al. 1998, 1999), a-
synuclein (Armstrong et al. 1997, 2004), and FUS im-
munoreactivity (Armstrong et al. 2011).  
 A major feature of the anatomical structure of 
the cerebral cortex is the replicated local neural circuit 
(represented by ‘columns’ or ‘modules’) (Hiorns et al. 
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Table 2. Summary of spatial patterns exhibited by the pTDP-43-immunoreactive neuronal cytoplasmic inclusions (NCI) in vari-
ous brain regions lobe (MFG = Middle frontal gyrus, ITG = Inferior temporal gyrus, PHG = Parahippocampal gyrus, CA1/2 = 
Sectors CA/2 of the hippocampus, DG = Dentate gyrus), U = Upper cortex, L = lower cortex) in cases of frontotemporal lobar 
degeneration with TDP-43 proteinopathy (FTLD-TDP). Column 6 indicates the proportion of analyses in which the cluster size 
of NCI in cortical regions was within the range 400 – 800 mm. (N = number of regions studied, R = Random distribution, Reg = 
Regular distribution).  
Region N R Reg 
Regular 
Clusters 
% (400-
800μm) 
Large cluster 
(>800 μm) 
MFG-U 27 8 3 13 50 3 
MFG-L 25 3 7 11 33 4 
ITG-U 26 7 1 13 35 5 
ITG-L 16 8 1 6 14 1 
PHG-U 22 4 5 10 38 3 
PHG-L 16 5 0 8 27 3 
CA1/2 18 5 3 8 - 2 
DG 25 4 5 15 - 1 
Chi-square (c2) contingency table analysis: Between brain regions; c2 = 25.79 (21DF, P > 0.05) 
1991). The diameter of individual cortical modules 
varies between 500-1000 μm depending on region and 
there are specific connections maintained between or-
dered sets of columns (Hiorns et al. 1991). In disorders 
characterized by tau, a-synuclein, and FUS immunore-
activity, the spatial patterns of the NCI clusters within 
the cerebral cortex and hippocampus suggested that the 
inclusions were related to this modular structure, most 
specifically, the cells of origin of specific cortico-
cortical and cortico-hippocampal projections 
(Delacoste & White 1993, Delatour et al. 2004, Hiorns 
et al. 1991). First, the cells of origin of the cortico-
cortical projections are themselves clustered and occur 
in bands that are more or less regularly distributed 
along the cortical strip. Second, individual bands of 
cells, approximately 500-800 μm in width traverse the 
cortical laminae in columns (Hiorns et al. 1991). In 
approximately 44 -66% of cortical regions studied, the 
clusters of NCI were regularly distributed parallel to 
the pia mater consistent with an association with these 
connections. However, in only a proportion of cortical 
areas (approx. 35%) did the estimated width of the 
NCI clusters approximate to the dimension of the cells 
of origin of the cortico-cortical projections. In the ma-
jority of cortical areas, the NCI developed in smaller 
clusters, usually between 50 and 200 μm in diameter, a 
size similar to the FUS-immunoreactive NCI in neu-
ronal intermediate filament inclusion disease (NIFID) 
(Armstrong et al. 2011). Hence, NCI may affect only a 
subset of cells within a cortical column and therefore 
are unlikely to completely explain neurodegeneration 
in FTLD-TDP. In some regions, however, clusters of 
NCI larger than 800 μm in diameter were present sug-
gesting that smaller clusters of inclusions could evolve 
into larger aggregations (Armstrong 1993b). Hence, 
there may be an increasing burden of pTDP-43 pathol-
ogy affecting the cortical columns as the disease pro-
gresses. 
 The data suggest degeneration of specific cor-
tico-cortical and cortico-hippocampal anatomical path-
ways associated with accumulation of cellular pTDP-
43 is characteristic of familial and sporadic FTLD-
TDP. Several different frame-shift and premature ter-
mination mutations have been identified in FTLD-TDP 
with GRN mutation (Beck et al. 2008). Abnormal pro-
tein products may accumulate within the endoplasmic 
reticulum of the cell due to inefficient secretion or mu-
tant RNA may have a lower expression within the cell 
at least in some mutants (Mukherjee et al. 2006). TDP-
43 is a nuclear protein but in FTLD-TDP, TDP-43 is 
redistributed from the nucleus to the cytoplasm, is 
ubiquinated, hyperphosphorylated, and then cleaved to 
generate C-terminal fragments (Neumann et al. 2007). 
These fragments may then accumulate to form the NCI 
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Figure 3. Mean cluster sizes (with SE of the mean) of the neuronal cytoplasmic inclusions (NCI) in frontotemporal lobar de-
generation with TDP-43 proteinopathy (FTLD-TDP) in different brain regions lobe (MFG = Middle frontal gyrus, ITG = Infe-
rior temporal gyrus, PHG = Parahippocampal gyrus, CA1/2 = Sectors CA/2 of the hippocampus, DG = Dentate gyrus), U = 
Upper cortex, L = lower cortex). Analysis of variance (ANOVA): One way (upper cortical data, CA1/2, DG) F = 1.33 (P > 
0.05), One way (lower cortical data, CA1/2, DG) F = 0.23 (P > 0.05); Two way between regions F = 0.26 (P > 0.05), Between 
upper and lower cortex F = 6.30 (P< 0.05), Interaction F = 0.27 (P >0.05) 
and cause cell death. Similar mechanisms may be in-
volved in FTLD-TDP associated with other types of 
genetic defect whereas in sporadic cases, the molecular 
mechanism responsible for TDP-43 accumulation 
(sFTLD-TDP) remains to be established.  
 The spatial patterns of the pTDP-43-
immunoreactive inclusions in FTLD-TDP could reflect 
cell to cell transfer of pathogenic proteins as postulated 
in other neurodegenerative disorders (Steiner et al. 
2011). Proteins such as tau and a-synuclein can exit 
host cells, transfer between cells, gain access to new 
cells, and create pathology within these cells (Steiner 
et al. 2011). For example, a-synuclein taken up from 
the extracellular space can induce aggregation of other 
a-synuclein proteins in recipient cells. By analogy with 
the scrapie form of prion protein (PrPsc), nucleation or 
seeding activity of a-synuclein may result in a core of 
an NCI of transferred a-synuclein surrounded by addi-
tional layers of cytoplasmic a-synuclein contributed by 
the host cell. It is possible that pTDP-43 has these 
properties and therefore, that cell to cell transfer of 
pTDP-43 may be a mechanism common to all forms of 
FTLD-TDP. The hypothesis of cell to cell transfer of 
pTDP-43 makes two predictions regarding the distri-
bution and abundance of the NCI:  (1) there should be 
a distinct spatial pattern of the NCI in brain regions 
affected by the disease and (2) an increasing burden of 
the pathology as it spreads from region to region. The 
observed spatial patterns of the pTDP-43 NCI are con-
sistent with both these predictions.  
  In conclusion, the spatial pattern of the pTDP-
immunoreactive NCI in FTLD-TDP is similar to that 
reported for cellular inclusions characterized by tau, a-
synuclein, and FUS immunoreactivity and also similar 
to that reported using a phosphorylation independent 
TDP-43 antibody (Armstrong 2011). In addition, cell 
to cell transfer of pTDP-43 could be involved in the 
pathogenesis of FTLD-TDP. 
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